116 related articles for article (PubMed ID: 33368526)
21. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
[TBL] [Abstract][Full Text] [Related]
22. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis.
Annibali V; Ristori G; Angelini DF; Serafini B; Mechelli R; Cannoni S; Romano S; Paolillo A; Abderrahim H; Diamantini A; Borsellino G; Aloisi F; Battistini L; Salvetti M
Brain; 2011 Feb; 134(Pt 2):542-54. PubMed ID: 21216829
[TBL] [Abstract][Full Text] [Related]
23. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
Moodycliffe AM; Maiti S; Ullrich SE
J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.
Rout N
PLoS One; 2016; 11(6):e0157407. PubMed ID: 27309719
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.
Cosmi L; Maggi L; Santarlasci V; Capone M; Cardilicchia E; Frosali F; Querci V; Angeli R; Matucci A; Fambrini M; Liotta F; Parronchi P; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2010 Jan; 125(1):222-30.e1-4. PubMed ID: 20109749
[TBL] [Abstract][Full Text] [Related]
26. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
27. Circulating CD4+CD161+ T lymphocytes are increased in seropositive arthralgia patients but decreased in patients with newly diagnosed rheumatoid arthritis.
Chalan P; Kroesen BJ; van der Geest KS; Huitema MG; Abdulahad WH; Bijzet J; Brouwer E; Boots AM
PLoS One; 2013; 8(11):e79370. PubMed ID: 24223933
[TBL] [Abstract][Full Text] [Related]
28. T-cell-mediated lysis of endothelial cells in acute coronary syndromes.
Nakajima T; Schulte S; Warrington KJ; Kopecky SL; Frye RL; Goronzy JJ; Weyand CM
Circulation; 2002 Feb; 105(5):570-5. PubMed ID: 11827921
[TBL] [Abstract][Full Text] [Related]
29. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.
Eger KA; Sundrud MS; Motsinger AA; Tseng M; Van Kaer L; Unutmaz D
PLoS One; 2006 Dec; 1(1):e50. PubMed ID: 17183680
[TBL] [Abstract][Full Text] [Related]
30. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.
Billerbeck E; Kang YH; Walker L; Lockstone H; Grafmueller S; Fleming V; Flint J; Willberg CB; Bengsch B; Seigel B; Ramamurthy N; Zitzmann N; Barnes EJ; Thevanayagam J; Bhagwanani A; Leslie A; Oo YH; Kollnberger S; Bowness P; Drognitz O; Adams DH; Blum HE; Thimme R; Klenerman P
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3006-11. PubMed ID: 20133607
[TBL] [Abstract][Full Text] [Related]
31. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
[TBL] [Abstract][Full Text] [Related]
32. TCR gamma delta+ and CD161+ thymocytes express HIV-1 in the SCID-hu mouse, potentially contributing to immune dysfunction in HIV infection.
Gurney KB; Yang OO; Wilson SB; Uittenbogaart CH
J Immunol; 2002 Nov; 169(9):5338-46. PubMed ID: 12391255
[TBL] [Abstract][Full Text] [Related]
33. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma.
González-Hernández Y; Pedraza-Sánchez S; Blandón-Vijil V; del Río-Navarro BE; Vaughan G; Moreno-Lafont M; Escobar-Gutiérrez A
Scand J Immunol; 2007 Apr; 65(4):368-75. PubMed ID: 17386028
[TBL] [Abstract][Full Text] [Related]
35. Discriminating Active Tuberculosis from Latent Tuberculosis Infection by flow cytometric measurement of CD161-expressing T cells.
Yang Q; Xu Q; Chen Q; Li J; Zhang M; Cai Y; Liu H; Zhou Y; Deng G; Deng Q; Zhou B; Kornfeld H; Chen X
Sci Rep; 2015 Dec; 5():17918. PubMed ID: 26643453
[TBL] [Abstract][Full Text] [Related]
36. Loss of CD28 within CD4
Escarra-Senmarti M; Bueno-Topete MR; Jave-Suarez LF; Gomez-Bañuelos E; Gutierrez-Franco J; Vega-Magaña N; Aguilar-Lemarroy A; Pereira-Suarez AL; Haramati J; Del Toro-Arreola S
Immunol Lett; 2017 Feb; 182():30-38. PubMed ID: 28087292
[TBL] [Abstract][Full Text] [Related]
37. T-cell receptor repertoire of human peripheral CD161hiTRAV1-2+ MAIT cells revealed by next generation sequencing and single cell analysis.
Held K; Beltrán E; Moser M; Hohlfeld R; Dornmair K
Hum Immunol; 2015 Sep; 76(9):607-14. PubMed ID: 26382249
[TBL] [Abstract][Full Text] [Related]
38. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function.
Mitson-Salazar A; Yin Y; Wansley DL; Young M; Bolan H; Arceo S; Ho N; Koh C; Milner JD; Stone KD; Wank SA; Prussin C
J Allergy Clin Immunol; 2016 Mar; 137(3):907-18.e9. PubMed ID: 26431580
[TBL] [Abstract][Full Text] [Related]
40. CD147-mediated chemotaxis of CD4
Lv M; Miao J; Zhao P; Luo X; Han Q; Wu Z; Zhang K; Zhu P
Clin Rheumatol; 2018 Jan; 37(1):59-66. PubMed ID: 28948414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
